InceptionR’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-33,801
Closed -$1.56M 689
2025
Q2
$1.56M Buy
+33,801
New +$1.66M 0.36% 56
2025
Q1
Sell
-18,030
Closed -$1.02M 566
2024
Q4
$1.02M Buy
+18,030
New +$1.01M 0.23% 156
2023
Q3
Sell
-17,464
Closed -$1.12M 407
2023
Q2
$1.12M Buy
+17,464
New +$1.17M 0.6% 9
2023
Q1
Sell
-13,898
Closed -$1,000K 438
2022
Q4
$1,000K Buy
+13,898
New +$1.05M 0.53% 25

Other funds holding BMY

InceptionR's BMY Position: Q3 2025 in Review

InceptionR sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 33,801 shares — an estimated $1.56M sold.

InceptionR first reported a position in BMY in Q4 2022 and held it in 4 quarters. The position peaked at $1.56M in Q2 2025. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • InceptionR reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • InceptionR sold 33,801 Bristol-Myers Squibb shares in Q3 2025, an estimated $1.56M.
  • InceptionR first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 4 quarters.
  • InceptionR's Bristol-Myers Squibb position peaked at $1.56M in Q2 2025.
  • 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on InceptionR's 13F filing for Q3 2025, filed 13 Nov 2025.